Cargando…

The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan

BACKGROUND: Portopulmonary hypertension (PoPH) refers to the simultaneous presentation of pulmonary arterial and portal hypertension. However, few reports have included the characteristics and treatments for patients with PoPH of Asian population; thus, we investigated the clinical characteristics,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Yukiko, Yamamoto, Keiko, Sakao, Seiichiro, Takeuchi, Takao, Suda, Rika, Tanabe, Nobuhiro, Tatsumi, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968246/ https://www.ncbi.nlm.nih.gov/pubmed/33726742 http://dx.doi.org/10.1186/s12890-021-01452-3

Ejemplares similares

Characteristics of patients meeting the new definition of pre-capillary pulmonary hypertension (Nice 2018) in a single Japanese pulmonary hypertension center
por: Yamamoto, Keiko, et al.
Publicado: (2021)

Heritable pulmonary arterial hypertension complicated by multiple pulmonary arteriovenous malformations
por: Arano, Takahiro, et al.
Publicado: (2021)

Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis
por: Sakao, Seiichiro, et al.
Publicado: (2019)

Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a concomitant psychiatric disorder
por: Tajima, Hiroshi, et al.
Publicado: (2019)

Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
por: Sakao, Seiichiro, et al.
Publicado: (2015)

The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study
por: Jujo-Sanada, Takayuki, et al.
Publicado: (2017)

Effectiveness of pulmonary vasodilators on pulmonary hypertension associated with POEMS syndrome
por: Ohashi, Kana, et al.
Publicado: (2019)

Endothelial-like cells in chronic thromboembolic pulmonary hypertension: crosstalk with myofibroblast-like cells
por: Sakao, Seiichiro, et al.
Publicado: (2011)

Portopulmonary hypertension
por: Saleemi, Sarfraz
Publicado: (2010)

Current Therapy and Liver Transplantation for Portopulmonary Hypertension in Japan
por: Tokushige, Katsutoshi, et al.
Publicado: (2023)

Nocturnal Hypoxemia and High Circulating TNF-α Levels in Chronic Thromboembolic Pulmonary Hypertension
por: Naito, Akira, et al.
Publicado: (2020)

Interventricular septal curvature as an additional echocardiographic parameter for evaluating chronic thromboembolic pulmonary hypertension: a single-center retrospective study
por: Matsumura, Akane, et al.
Publicado: (2021)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan
por: Ikubo, Yumiko, et al.
Publicado: (2022)

Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment
por: Yanagisawa, Asako, et al.
Publicado: (2021)

The Development of Marked Collateral Circulation due to Inferior Vena Cava Filter Occlusion in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated with Anti-phospholipid Syndrome
por: Kasai, Hajime, et al.
Publicado: (2017)

Impact of residual pulmonary hypertension on long‐term outcomes after pulmonary endarterectomy in the modern era
por: Ishida, Keiichi, et al.
Publicado: (2023)

Psychometric Validation of a Japanese Version of the emPHasis-10 Questionnaire, a Patient-Reported Outcome Measure for Pulmonary Hypertension　― Multicenter Study in Japan ―
por: Takeyasu, Rika, et al.
Publicado: (2020)

Pentraxin3 in Chronic Thromboembolic Pulmonary Hypertension: A New Biomarker for Screening from Remitted Pulmonary Thromboembolism
por: Naito, Akira, et al.
Publicado: (2014)

Partial anomalous pulmonary venous return with dual drainage to the superior vena cava and left atrium with pulmonary hypertension
por: Tanaka, Nozomi, et al.
Publicado: (2018)

Treatment pattern and clinical outcomes in portopulmonary hypertension: A database study in Japan
por: Atsukawa, Masanori, et al.
Publicado: (2022)

Portopulmonary Hypertension: An Updated Review
por: Jasso-Baltazar, Erick A., et al.
Publicado: (2023)

Electrocardiogram-Gated 320-Slice Multidetector Computed Tomography for the Measurement of Pulmonary Arterial Distensibility in Chronic Thromboembolic Pulmonary Hypertension
por: Kasai, Hajime, et al.
Publicado: (2014)

The Role of Matrix Metalloproteinase in the Intimal Sarcoma-Like Cells Derived from Endarterectomized Tissues from a Chronic Thromboembolic Pulmonary Hypertension Patient
por: Jujo, Takayuki, et al.
Publicado: (2014)

Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry
por: Tamura, Yudai, et al.
Publicado: (2022)

Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat model
por: Sanada, Takayuki J., et al.
Publicado: (2020)

Pulmonary Hypertension that Developed During Treatment for Hepatopulmonary Syndrome and Pulmonary Arteriovenous Malformation
por: Ikubo, Yumiko, et al.
Publicado: (2019)

The extent of enlarged bronchial arteries is not correlated with the development of reperfusion pulmonary edema after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension
por: Ikubo, Yumiko, et al.
Publicado: (2020)

Severe thrombocytopenia in patients with idiopathic pulmonary arterial hypertension provided several strategies for lung transplantation
por: Kobayashi, Takayuki, et al.
Publicado: (2020)

Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study
por: Nagata, Jun, et al.
Publicado: (2022)

The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
por: Sakao, Seiichiro, et al.
Publicado: (2014)

Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension
por: Jujo, Takayuki, et al.
Publicado: (2016)

Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation
por: Sakao, Seiichiro, et al.
Publicado: (2009)

Portopulmonary Hypertension: From Bench to Bedside
por: Thomas, Christopher, et al.
Publicado: (2020)

Causes and Circumstances of Death in Portopulmonary Hypertension
por: Sahay, Sandeep, et al.
Publicado: (2021)

Partially hydrolyzed guar gum suppresses the progression of pulmonary arterial hypertension in a SU5416/hypoxia rat model
por: Sanada, Takayuki J., et al.
Publicado: (2023)

Current clinical understanding and effectiveness of portopulmonary hypertension treatment
por: Tamura, Yuichi, et al.
Publicado: (2023)

Portopulmonary hypertension: Success with combined medical treatment
por: Hernández, María, et al.
Publicado: (2023)

Characterization of pulmonary intimal sarcoma cells isolated from a surgical specimen: In vitro and in vivo study
por: Sanada, Takayuki Jujo, et al.
Publicado: (2019)

Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan
por: Tamura, Yuichi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cbq230kfqs50qoa546f4kqd2l4